Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Acasti Pharma, Inc.
Acasti Pharma Reports Third Quarter 2023 Operational Results
February 14, 2023
From
Acasti Pharma, Inc.
Via
GlobeNewswire
Tickers
ACST
TSX-V:ACST
Acasti Receives Extension to Regain Compliance with NASDAQ Minimum Bid Price Rule
January 25, 2023
From
Acasti Pharma, Inc.
Via
GlobeNewswire
Tickers
ACST
TSX-V:ACST
Acasti Pharma to Present at Lytham Partners Investor Select Conference on January 31
January 24, 2023
From
Acasti Pharma, Inc.
Via
GlobeNewswire
Tickers
ACST
TSX-V:ACST
Acasti Pharma to Present at Sidoti Virtual Investor Conference on January 18
January 13, 2023
From
Acasti Pharma, Inc.
Via
GlobeNewswire
Tickers
ACST
TSX-V:ACST
Acasti to Host Conference Call on Tuesday, January 10, 2023 to Discuss Results from Recent Phase 1 PK Studies for GTX-101 and GTX-102 That Met All Outcome Measures
January 05, 2023
From
Acasti Pharma, Inc.
Via
GlobeNewswire
Tickers
ACST
TSX-V:ACST
Acasti Announces Preliminary Topline Results Met All Outcome Measures in the Pharmacokinetic Bridging Study for GTX-102, the Company’s Drug Candidate for the Treatment of Ataxia Telangiectasia
December 28, 2022
From
Acasti Pharma, Inc.
Via
GlobeNewswire
Tickers
ACST
TSX-V:ACST
Acasti Pharma Announces Preliminary Topline Results Met All Primary Outcome Measures in the Single Dose Pharmacokinetic Study for GTX-101, the Company’s Drug Candidate for the Treatment of Postherpetic Neuralgia (PHN)
December 22, 2022
From
Acasti Pharma, Inc.
Via
GlobeNewswire
Tickers
ACST
TSX-V:ACST
Acasti Pharma Reports Second Quarter 2023 Operational Results
November 14, 2022
From
Acasti Pharma, Inc.
Via
GlobeNewswire
Tickers
ACST
TSX-V:ACST
Acasti Pharma to Present at Q4 Investor Summit
November 09, 2022
From
Acasti Pharma, Inc.
Via
GlobeNewswire
Tickers
ACST
TSX-V:ACST
Acasti Pharma to Report Second Quarter 2023 Financial Results on Monday, November 14, 2022
November 07, 2022
From
Acasti Pharma, Inc.
Via
GlobeNewswire
Tickers
ACST
TSX-V:ACST
Acasti Announces Court Dismissal of Stockholder Litigation
September 30, 2022
From
Acasti Pharma, Inc.
Via
GlobeNewswire
Tickers
ACST
TSX-V:ACST
Acasti Announces Voting Results from 2022 Annual and Special Meeting of Shareholders
September 29, 2022
From
Acasti Pharma, Inc.
Via
GlobeNewswire
Tickers
ACST
TSX-V:ACST
Acasti Pharma Announces Initiation of Pharmacokinetic Study for GTX-101, the Company’s Drug Candidate for the Treatment of Postherpetic Neuralgia
July 27, 2022
From
Acasti Pharma, Inc.
Via
GlobeNewswire
Tickers
ACST
TSX-V:ACST
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.